Languages

• English, fluent.

Publications

• 1: Sherwin CM, Zobell JT, Stockmann C, McCrory BE, Wisdom M, Young DC, Olson J, Ampofo K, Spigarelli MG. Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis. J Pharmacokinet Pharmacodyn. 2014 Feb;41(1):71-9. doi: 10.1007/s10928-013-9348-7. Epub 2014 Jan 7. PubMed PMID: 24395072. Published, 01/2014.
• Young DC, Zobell JT, Stockmann C, Waters CD, Ampofo K, Sherwin CM, Spigarelli MG. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides. Pediatr Pulmonol. 2013 Nov;48(11):1047-61. doi: 10.1002/ppul.22813. Epub 2013 Sep 2. Review. PubMed PMID: 24000183. Published, 09/02/2013.
• Stockmann C, Sherwin CM, Zobell JT, Lubsch L, Young DC, Olson J, Noyes BE, Ampofo K, Spigarelli MG. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis. Pharmacotherapy. 2013 Dec;33(12):1288-96. doi: 10.1002/phar.1320. Epub 2013 Jul 3. PubMed PMID: 23824677. Published, 07/03/2013.
• Zobell JT, Ferdinand C, Young DC. Continuous infusion meropenem and ticarcillin-clavulanate in pediatric cystic fibrosis patients. Pediatr Pulmonol. 2014 Mar;49(3):302-6. doi: 10.1002/ppul.22820. Epub 2013 Jun 17. PubMed PMID: 23775821. Published, 06/17/2013.
• Zobell JT, Kemper AL, Young DC. The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages. Pediatr Pulmonol. 2014 Mar;49(3):E48-51. doi: 10.1002/ppul.22798. Epub 2013 May 9. PubMed PMID: 23661625. Published, 05/09/2013.
• Zobell JT, Young DC, Waters CD, Ampofo K, Stockmann C, Sherwin CM, Spigarelli MG. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary. Pediatr Pulmonol. 2013 Jun;48(6):525-37. doi: 10.1002/ppul.22757. Epub 2013 Jan 28. Review. PubMed PMID: 23359557. Published, 01/28/2013.
• Zobell JT, Waters CD, Young DC, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins. Pediatr Pulmonol. 2013 Feb;48(2):107-22. doi: 10.1002/ppul.22669. Epub 2012 Sep 4. Review. PubMed PMID: 22949297. Published, 09/04/2012.
• Stockmann C, Sherwin CM, Zobell JT, Young DC, Waters CD, Spigarelli MG, Ampofo K. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones. Pediatr Pulmonol. 2013 Mar;48(3):211-20. doi: 10.1002/ppul.22667. Epub 2012 Sep 4. Review. PubMed PMID: 22949224. Published, 09/04/2012.
• Young DC, Zobell JT, Waters CD, Ampofo K, Stockmann C, Sherwin CM, Spigarelli MG. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium. Pediatr Pulmonol. 2013 Jan;48(1):1-7. doi: 10.1002/ppul.22664. Epub 2012 Sep 4. PubMed PMID: 22949160. Published, 09/04/2012.
• Zobell JT, Young DC, Waters CD, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems. Pediatr Pulmonol. 2012 Dec;47(12):1147-58. doi: 10.1002/ppul.22655. Epub 2012 Aug 21. Review. PubMed PMID: 22911974. Published, 08/21/2012.
• Zobell JT, Young DC, Chatfield BA. Intermittent and extended-infusion beta-lactam utilization in cystic fibrosis. Pediatr Pulmonol. 2013 Jun;48(6):622-3. doi: 10.1002/ppul.22641. Epub 2012 Jul 23. PubMed PMID: 22825925. Published, 07/23/2012.
• Pohl JF, Patel R, Zobell JT, Lin E, Korgenski EK, Crowell K, Mackay MW, Richman A, Larsen C, Chatfield BA. Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients. Gastroenterol Res Pract. 2011;2011:345012. doi: 10.1155/2011/345012. Epub 2011 Nov 15. PubMed PMID: 22144994; PubMed Central PMCID: PMC3226314. Published, 11/15/2011.
• Zobell JT, Stockmann C, Young DC, Cash J, McDowell BJ, Korgenski K, Sherwin CM, Spigarelli M, Chatfield BA, Ampofo K. Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients. Clin Ther. 2011 Nov;33(11):1844-50. doi: 10.1016/j.clinthera.2011.09.010. Epub 2011 Oct 21. PubMed PMID: 22018680. Published, 10/21/2011.
• Zobell JT, Young DC, Waters CD, Ampofo K, Cash J, Marshall BC, Olson J, Chatfield BA. A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients. Pediatr Pulmonol. 2011 Oct;46(10):987-90. doi: 10.1002/ppul.21467. Epub 2011 Apr 25. PubMed PMID: 21520438. Published, 04/25/2011.
• Zobell JT, Ampofo K, Cash J, Korgenski K, Chatfield BA. High dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients. J Cyst Fibros. 2010 Jul;9(4):280-3. doi: 10.1016/j.jcf.2010.04.003. Epub 2010 May 15. PubMed PMID: 20472513. Published, 05/15/2010.